Ji Yu-Xiao, Zhang Hong-Yan, Lin Shu-Xiang
Department of Cardiology, Tianjin Children's Hospital, Tianjin, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2013 Mar;15(3):196-200.
To study the association of FCGR2A gene single nucleotide polymorphism (SNP) rs1801274 with Kawasaki disease (KD) susceptibility and the efficacy of intravenous immunoglobulin (IVIG) therapy in Han Chinese children.
Thirty-five KD children and 25 age-and gender-matched healthy children (control group) were enrolled in the study. Polymerase chain reaction (PCR) and gene sequence analysis were applied to detect SNP of FCGR2A gene rs1801274. These KD patients were classified into two subgroups based on the presence of coronary artery lesion (CAL) following IVIG therapy: CAL (n=13) and non-CAL (n=22).
FCGR2A gene SNP rs1801274 was detected in all subjects, including three genotypes (AA, AG and GG). For FCGR2A gene SNP rs1801274, there were significant differences in the genotype and allele frequencies between the KD and control groups (P<0.05), and significant differences in the genotype and allele frequencies were also found between the CAL and non-CAL subgroups (P<0.05). A allele and AA genotype were linked to an increased risk of KD susceptibility (A allele: OR=3.39, 95%CI:1.53-7.50; AA genotype: (OR=4.93, 95%CI:1.61-15.1). Both AG (OR=5.43, 95%CI:1.06-27.8) and G allele (OR=4.88, 95%CI:1.44-16.5) were linked to an increased risk of CAL in KD children.
Polymorphism of the FCGR2A gene SNP rs1801274 is one of the important factors probably influencing susceptibility to KD and efficacy of IVIG therapy on KD in Han Chinese children.
研究FCGR2A基因单核苷酸多态性(SNP)rs1801274与川崎病(KD)易感性以及静脉注射免疫球蛋白(IVIG)治疗汉族儿童KD疗效的相关性。
本研究纳入35例KD患儿和25例年龄及性别匹配的健康儿童(对照组)。采用聚合酶链反应(PCR)和基因序列分析检测FCGR2A基因rs1801274的SNP。这些KD患者根据IVIG治疗后冠状动脉病变(CAL)的情况分为两个亚组:CAL(n = 13)和非CAL(n = 22)。
在所有受试者中均检测到FCGR2A基因SNP rs1801274,包括三种基因型(AA、AG和GG)。对于FCGR2A基因SNP rs1801274,KD组与对照组之间的基因型和等位基因频率存在显著差异(P < 0.05),CAL亚组与非CAL亚组之间的基因型和等位基因频率也存在显著差异(P < 0.05)。A等位基因和AA基因型与KD易感性增加相关(A等位基因:OR = 3.39,95%CI:1.53 - 7.50;AA基因型:OR = 4.93,95%CI:1.61 - 15.1)。AG(OR = 5.43,95%CI:1.06 - 27.8)和G等位基因(OR = 4.88,95%CI:1.44 - 16.5)均与KD患儿发生CAL的风险增加相关。
FCGR2A基因SNP rs1801274的多态性可能是影响汉族儿童KD易感性及IVIG治疗KD疗效的重要因素之一。